<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 212 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page211.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=212">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 212 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 212</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=212"><img src="../thumb/212.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Gastro-Intestinal Tract - 12.4.4                                               2020-04 / 177
       Maint.for prevent of gastro-oesophag.reflux: 15 mg dly for   (S4) CAPS, 36/11.4.3/0446  NSAID assoc.prophylax: 20 mg once dly.
       up to 1 yr.                   705466-001: 20 mg, 30, R175,32  Symptomat.gastro-oesophag.reflux dis: 20 mg dly. Indiv.as some
       Function.dyspeps: 15 –30 mg dly for 2-4 wks.  Dosage: Swallow whole.  may respond to 10 mg dly. Investigate further if sympt.control not
       (S2) OTC CAPS, 37/11.4.3/0238  Adults:                     achiev. within 4 wks.on 20 mg dly.
       Indications: Short-term relief of heartburn & hyperacid.  Duod.ulc: 20 mg dly.x2-4 wks. In pts.refract.to other treatm: 40 mg   Funct.dyspeps: 20 mg once dly. Consid.10 mg dly.as start.dos.as
       704752-001: 15 mg, 7, R31,10  dly.may be effect. Prev.of relapse: 10 mg once dly.if necess.incr.to   adeq.respons.report. Investig. furth.if sympt.contr.not achiev.aft.2
       Dosage: . Swall.whole without crush./chew.  20-40 mg once dly. Above recomm.regim.are incl.of H.Pylori assoc.   wks.at 20 mg dly.
       Admin.1x dly.bef.meals. Max.dly.dos: 15 mg for durat.max.14 days  duod.ulc.with suit.antibiot.  Zollinger-Ellison syndr: Init. 60 mg dly. Adjust indiv., av.maint.betw.
       Contraindications: Pregn., lactat., liv.impairm., safety & effic.in   Gastric.ulc.& reflux oesophagit: 20 mg dly. x4-8 wks. When   20-120 mg dly. Doses over 80 mg admin.in 2 div.doses.
       childr.not est., concom. atazanavir., OTC Caps.not suit.in fruct.intol./  refract.to other treatm.regimens 40 mg once dly.may be effect.   Contraindications: Safety in pregn.not est., excret. in breast milk.
       gluc.-galact. malabsorpt.syndr./sucr.isomalt.defic.  Long-term reflux oesophagit.mangem: 20-40 mg once dly.if necess.   Side effects: GI disturbs., stomatit., candidias., CNS effs., paraes-
       Side effects: Headache, dizzin., fatig., malaise, candidias., oral   In sev./symptomat. recurr. reflux oesophagit.contin.with 20 mg dly.  thes., malaise, skin disords.incl. Stev. Johns./tox.epiderm.necrolys.&
       monilias., pneumon., URTI, UTI, Ca, laryng. neoplasma, bld.dyscras.,   NSAID-assoc.gastroduod.les.with/without contin.NSAID   erythema multiforme, fev., photosens., angio-oed., alopec., arthrit.
       lymphadenopathy, bruis., petechiae, allerg./hypersens.react.incl.   treatm: 20 mg once dly.x4wks. If heal.not compl.contin.xfurth.4 wks.  & myalg.sympts., musc.weakn., blurr.vis., aggress., periph.oed., hy-
       angioed./ wheez./fev./anaphylax., diab.mellit., goitre, hypothyroid.,   NSAID-assoc.gastroduod.les.&dyspept. sympt. prophylax.:   ponatraem., incr.sweat., gynaecomast., bronchosp., bld.dyscras., hy-
       GI disturbs.incl.ulcerat.colit./ haemorrh., stomatit., tenesm., bezoar,   20 mg once dly.  persens. reacts. incl.anaphylax., encephalopathy with sev. pre-exist.
       glossit., thirst, gout, dehydrat., hyper-/hypoglycaem., weight chang.,   Symptomat.gastro-oesophag.reflux dis: 20 mg dly. Investig.furth.  liv.dis., hepatit.with/without jaund., hepat. fail., incr.freq.of gastr.glan-
       hyponatream., CNS effs., CV accid., cerebr.infarct., psych.disords.incl.  if sympt. contr.not achiev.aft.2 wks.treatm.at 20 mg dly.  dul.cysts with long-term treatm., incr.liv.enzymes.
       hallucinat., libido chang., migraine, convuls., hemipleg., hyperkines.,   Zollinger-Ellison syndr: Init.60 mg dly. Indiv.& contin. as long as   Special precautions: Not indic.for mild GI complaints, limit.paed.
       hyper-paraesthes., tremor, parosm., vis.disturbs. incl. retin.degenerat./  clinic.reqd. Admin.dos.over 80 mg dly.in 2 div.dos.  exper., excl.poss.malign., imp. hepat.funct., monit.pts.on warfar./
       vis.field defect, eye/ oesophag./ musculoskelet./back/chest/neck/  Childr.1 yr & old.: (Limit.exper.)  phenytoin ther., incr.GI Salmonella & Campylobacter.infect. risk
       pelv./ kidn./ urethr./breast pain, conjunctivit., vertigo, deafn., otit.med.,   Sev.ulcerat.reflux oesophagit: Over 20 kg: 20 mg once dly.incr.  Drug interactions: Poss.interacts.with meds.also metabol.via cy-
       tinnit., card.disords.incl.MI, dysrhythm., palpitat., oed., hypo-/hyper-  to 40 mg once dly.if necess.  tochrome P450 enzyme syst., ketoconazole & itraconazole absorpt.
       tens., shock, asthma, bronchit., dyspn., epistax., haemoptys., pleur.  Contraindications: Other benzimidaz. hypersens., concom.nelfina-  decr., prolongs diazepam, warfarin & phenytoin eliminat., plasma
       disord., stridor, incr.hepat. enzym., cholelithias., hepatit., hepat.fail./   vir/atazanavir & clopidogrel  conc.of omeprazole & clarithromycin incr. with concom.admin.,
       encephalopathy, skin reacts.incl.erythema multiforme/ Stev.Johns.  Side effects: Bld.dyscras., hypersens.reacts. incl. anaphylax., hy-  incr.digox.bioavail.
       syndr./tox.epiderm. necrolys., alopec., photosens., arthralg., myalg.,   ponatraem., hypomagnesaem., hypocalcaem., hypokalaem., in-
       arthrit., bone/joint disord., myasthen., sinovit., gynaecomast., galact-  somn., agitat., revers.ment.confus., aggress., hallucinat., depress.,   MYLAN PANTOPRAZOLE, (Mylan) Xixia [P/S]
       orrh., asthen., ren./urin. disords., interstit.nephrit.with poss.progress.  CNS effs., paraesthes., malaise, fev., blurr. vis., vertigo, tinnit., pe-  Pantoprazole., sodium sesquihydrate (equiv.to pantoprazole)
       to ren.fail., menstr./penis/testis disord., vaginit., impot., dysmenorrh.,   riph. oed., angina, tachy-/ bradycard., bronchosp., cough, GI disturbs.,   Indications: 40 mg tabs: Short-term treatm.of duod.& gastr. ulc.,
       breast tendern./enlargem., chills, flu syndr., gastric.gland.cysts dur.  gastr.glandul.cysts, acid regurgitat., incr. GI bact., pancreatit., incr.liv.   reflux oesophagit., duod.ulc. assoc.with H.pylori infect.in combinat.
       long term treatm., incr. GI infect.risk due to incr.norm.GIT bact. counts.  enzymes, hepatit.with/-out jaund., hepat. encephalopathy, hepat.ne-  with appropr. antibiot., Zolling.-Ellison syndr.
       Special precautions: Pass.into milk of rats & caus.tumorigen.effs.in   cros., skin reacts.incl. erythema multiforme, prurit., photosens., tox.   20 mg tabs: Mild gastro-esophageal reflux dis (GERD) & the long
       anim., excl.malign.bef.init. ther.esp.in old.pts.with new/recent.chang.  epiderm. necrolys.& Stev.John.syndr., alopec., asthen., arthralg.&   term managem.& relapse prevent. thereof, prevent.of NSAID-induc.
       dyspept. sympt., concom. theophyll./OC’s/carbamazepine, admin.at   myalg., musc.weakn., hip/ wrist or spine fract., interstit.nephrit.,   gastro-duod.les.& dyspept.sympt.in pts.at risk & need. contin.treatm.
       least 30 mins.bef.sucralfate, antacids not to be giv.with.1 hr of ther.,   gynaecomast., incr.sweat.  (S4) TABS, 44/11.4.3/0843, 0844
       reflex oesophagit.diagn.to be confirm.by endoscopy, monit.concom.  Warnings and special precautions: Not indicat. for min.GI   717420-001: 20 mg, 30, R118,90
       warfar.as min.warfar.conc. reduct. poss., discont.ther.if persist. diarrh.  complaints, limit.exper.in childr., excl. poss. malign., monit.pts.on   717421-001: 40 mg, 30, R185,08
       devel., OTC Caps.not for mild GI compl.  long-term treatm.(ie &gt;1 yr), Vit B12 absorpt.reduc. theref. consid.in   Dosage: Admin.recomm.dos.in the morn.bef./dur. breakf.
       Drug interactions: Incr.theophyll.clear., reduc. bioavail.with ant-  pts.with reduc.body stores/risk fact. for reduc.absorpt., consid.poss.  Duod.ulc: 40 mg once dly. x2-4 wks. Use in combinat. with appropr.
       acids, atazanavir expos.reduct., as weak induc.of cytochrome P450   interacts. with other meds.metabol.through CP2C19, monit. for poss.  antibiot.when assoc.with H.Pylori.
       enzyme syst. interacts. with drugs metabol.by this syst.poss., delay.  effs.of hypomagnesaem./concom.meds. caus. hypomagnesaem., incr.  Gastr.ulc.& reflux oesophagit: 40 mg once dly. x4-8 wks.
       absorpt.with sucralphate, poss.interfer.with absorpt.of meds.where   risk of hip/wrist & spine fract.with long term high dos.ther.in elderly   Zolling.Ellison syndr: Init.80 mg/day, thereaft. titrat.up/down
       gastr.pH is determin.of bioavailabil., conc.of both meds. incr.with   or in pres.of other recogn.risk fact., osteoporos. risk pts., incr.risk of   accord.to gastric acid secret. Dly. dos. above 80 mg/day to be ad-
       voriconazole, drowsin.aggrav.by alcoh.& CNS depress.  GI infects.due to decr.acid. incr. gastr.bact.counts, imp.hepat.funct.,   min.in 2 div.dos.
       LANSOPRAZOLE UNICORN, Unicorn [P/S]  incr. freq.of gastric glandul.cysts report.with long term use, eval.  Mild GERD: 20 mg/day x4-8 wks. Recurr.sympt. contr. by 20 mg
                                                                  once dly on demand.
       Lansoprazole                  poss.S/E on driv.ability & hazard. machine operat., diab., sucrose   Longt./GERD relapse prev: Recomm.maint. 20 mg/day incr.to
       Indications: (S4) 30 mg: Short-term treatm.of gastric/ duod. ulc. &   and lact. intol., high dos.ther.in elderly on digox.when monit. advis.,
       reflux oesophagit. 15 mg: Short-term managem.of mild funct.dys-  monit.concom.INR/phenytoin lev., consid. withdr. ther.with high-dos.  40 mg/day in case of relapse reduc.to 20 mg/day aft.heal.
                                                                  NSAID induc.gastro-duod.les.& dyspeps. sympt: Recomm.
       peps., gastro-oesophag.reflux relapse prophylax. In conjunct.with ap-  methotrex. admin., safety in pregn./lactat.not est., long term use in
       propr. antibiot.as part of eradicat. program.for H.Pylori-posit.duod.ulc.  ren./ hepat.impairm.not est.  dos.20 mg once dly.
                                                                  Contraindications: Safety & effic.in childr.not est., sev.liv.funct.im-
       (S2) 15 mg: Short term symptomat.heartburn & hyperacidity at   Interactions: Incr./decr.absorpt.of meds with gastric PH depend.
       max.15 mg dly dos.for max.14 days.  absorpt., nelfinavir & atazanavir plasma lev.decr., digox.bioavailabil.   pairm., concom.atazanavir, safety in pregn.& lactat.not est.
                                                                  Side effects: Bld.dyscras., GI disturbs., periph. oed., sev.hepatocel-
       (S4) & (S2) CAPS, 40/11.4.3/0249, 0250  incr., expos.to clopidogrel act.metabol.decr., absorpt. of posconazole/
       715079-002: 15 mg, 14, R57,31  dasatinib/erlotinib/ ketoconaz. & itraconaz.signif.reduc.imp.clinic. ef-  lul.damage lead.to jaund.with/ without liv.fail., anaphylact.reacts.
       715079-001: 15 mg, 30, R122,82  fic., metabol.of other meds.metabol.by hepat. P450 cytochrome en-  incl.shock, incr. liv.enzym., elev.triglycerid., incr.body temp., arthralg.,
       715080-001: 30 mg, 30, R158,88  zyme poss.affect., prolong. elimin. of diazepam/warfar/other vit.K   myalg., headache, dizzin., blurr.vis., depress., interstit.nephrit., allerg.
       Dosage: Take pref.bef.meals using low.dos.& short.durat.  antagon./ cilostazol & phenytoin, fluvoxam.incr.expos.in extens. me-  reacts.incl.sev. skin reacts.such as Stev.-John./ Lyell’s syndr./ erythem.
       Gastr.ulc: 30 mg once dly.for upto 8 wks.  tabolis., saquinavir/ritonavir/ tacrolimus plasma lev.incr., methotrex.  multiforme, photosens.
       Duod.ulc: 30 mg once dly.for upto 4 wks. As part of eradicat.pro-  lev.incr., subst. known to inhib.CYP2C19/CYP3A4 may incr. Lokit ser.  Special precautions: 40 mg Tabs.cont. tartrazine, aspir.cross-sens.,
       gram.with appropr.antibiot.for H.pylor posit.ulc.  lev.while induc.will decr.Lokit ser. lev, with concom.voriconaz.expos.  excl.poss.malign., not to exceed 20 mg dly in mild-mod.liv.impairm.,
       Oesophagit.due to gastro-oesophag.reflux: 30 mg once dly.x4   to both meds. incr.theref.dos.adjustm.poss.necess.in sev. hepat. im-  monit. liv.enzym.reg.in sev.impairm.esp.dur.longt. use & discont.
       wks., rep.4 wk.course poss. necess.  pairm./long term ther., plasma conc. incr. with clarithromycin, absorpt.  if elev., not indic.for mild GI compl., may allev. malign.ulc.sympt.&
       Gastro-oesophageal reflux prevent: Maint: 15 mg once dly.  of Vit.B 12 reduc., concom. CNS depress.& alcoh.may potent.any CNS   delay diagn., confirm reflux oesophag.diagn.by endoscopy, poss.
       for max.1 yr.                 eff., elimin.of diazepam/warfar.& phenytoin prolong.  cyanocobalam. malabsorpt.with prolong.treatm. (ie.&gt;3 yrs.), monit.
       Funct.dyspeps: Adults: 15-30 mg once dly.x2-4 wks. Elderly: Max.  LOSEC, AstraZeneca [P/S]  prothromb.time/INH esp.when ther. init./discont./admin.irreg., exper.
       dly dos: 30 mg.               Omeprazole.                  in longt. admin.limit., cont.NSAID treatm.in risk pts.
       Heartburn & hyperacidity: 15 mg dly.for up to max.14 days. Con-  Indications: Adults: Duod.ulc.incl.relap.prev., gastr.ulc., reflux oe-  Drug interactions: Poss.changes in absorpt.of pH-depend.meds.
       sult practit.should sympt.persist / get worse/cont.dur.or aft.treatm.  sophagit.incl.long-term managem., Zollinger-Ellison syndr., symp-  eg. ketoconazole/ampicill. esters/ Fe salts, poss.interacts.with oth-
       Contra-indications: Pregn.& lactat., liv.impairm., safety & effic.  tomat. heartburn rel., gastro-oesophag.reflux dis., short-term rel.  er meds. metab.by hepat.cytochrome P450-enzyme syst., anticoag.
       in childr.not est., heredit.probl./ galact. intol.hist., Lapp lact.defic.,   of funct. dyspeps., duod.ulc.assoc.with H.pylori infect.in combinat.  respons.poss.affect.
       gluc.-galact. malabsorpt.     with appropr.antibiot., NSAID assoc. gastric and/duod.ulc./reduc.  NECTIZOLE, (Activo) Abex [P/S]
       Side effects: Bld.dyscras., oed., CNS effs., headache, dizzin., tremor,   the assoc. risk of develop.such ulc.& reduc.the poss.of relapse of   Esomeprazole magnes.dihydr.equiv.to esomeprazole
       GI disturbs.incl. ulcerat.colit., dry mouth, glossit., gynaecomast., ga-  such assoc.ulc.  Indications: Eros.reflux oesophagit., relapse prophylax. in heal.
       lactorrh., elev.hepat.enzym., asthen., arthralg., myalg., blurr.vis., skin   Childr: Short term treatm.of sev.ulcerat.reflux oesophagit.  oesophagit., symptomat.treatm. of GORD, prevent.of gastr.& duod.
       reacts., alopec., fev., incr. freq.of gastr.glandul.cysts.dur long term   (S4) MUPS TABS. 32/11.4.3/0222, 0223  ulc.assoc.with NSAID ther., in combin.with appropr.antibiot.in duod.
       treatm.& incr.gastric.bact.counts result.from inhibit.of gastr. acid se-  849383-005: 10 mg, 28, R420,12  ulc.heal.& relapse prevent.of pept.ulc. assoc. with H.pylori infect.,
       cret.incr.risk of GIT infects.  849391-016: 20 mg, 28, R701,41  patholog.hypersecret. condits.incl.Zollinger-Ellison syndr.& idi-
       Special precautions: Excl.malign.bef.init.ther.as treatm. poss.al-  Dosage: Swallow whole in morn., do not chew or crush. Disperse   opath. hypersecret.
       lev.sympt.& delay diagn., monit. concom.warfar., distrib.into milk of   in water/fruit juice and take within 30 mins.  (S4) GASTRO-RESIST.TABS. 48/11.4.3/0438, 0439
       lactat.rats, poss.tumorigen.effs.in animals, confirm.reflux. oesophagit.  721061-001: 20 mg, 30, R220,54
       diagnos. by endoscopy, incr.clostrid. diffic.assoc.diarrh.risk.  Duod.ulc: 20 mg dly x2-4 wks.  721062-001: 40 mg, 30, R329,30
                                     Relapse prev: 10 mg once dly.if need.incr.dose to 20-40 mg dly.
       Drug interactions: Sedat.eff.potent.by CNS depress. & alcoh.,   Dosage: Admin.at least 30 mins. bef.meals. Do not chew/crush.
       poss.interacts.with drugs metabol. by cytochrome P450 syst., war-  H.pylori posit.duod.ulc: Losec as part of the eradicat. programme   May be dispers.in non-carbon. water if diffic.swall. Admin.low.dos.&
                                     with appropr.antibiot.
       far.conc. poss.reduc.
                                     Gastr.ulc.& reflux oesophagit: 20 mg dly x4-8 wks.  for short. treatm. durat.
       LOKIT, (Cipla) Pharmascript [P/S]  Gastr.ulc.& reflux oesophagit: Refract.to other treatm.regimens:   Adults & adolesc.from 12 yrs:
       Omeprazole                    40 mg once dly.may be effect.  Eros.reflux oesphagit: 40 mg once dly.x4 wks. Addit.4 wks.recomm.
       Indications: Adults: Duod.ulc.incl.prev.of relapse, gastr.ulc., reflux   Reflux oesophagit.long-term treatm: 10 mg once dly incr.to 20-  if not heal./sympts.persist.
       oeosphagit., Zollinger-Ellison syndr., gastro-oesophag.reflux dis.   40 mg once dly.if need.  Longt.relapse prevent.of heal.oesophagit: 20 mg once dly.
       (GORD), funct. dyspeps., duod.ulc.assoc.with H Pylor infect.in combi-  Sev/recurr.reflux oesophagit: contin.with 20 mg dly.  Symptomat.GORD: Without oesophagit.admin. 20 mg once dly.
       nat.with suit.antibiot., treatm. of NSAID’s assoc.gastr.&/or duod.ulc.&   Sev.ulcerat.reflux oesophagit.in childr.1 yr. & old: 10-20 kg:   Furth.investig.if sympt.contr.not achiev. aft.4 wks. Admin.20 mg once
       eros., reduc.risk of develop.gastric and/or duod. ulc. /eros.,reduc.risk   10 mg once dly. &gt;20 kg: 20 mg once dly. If necess.incr.dos.to 20 mg   dly.if necess. when sympt.resolv.
       of relapse of prev.heal. gastr. &/or duod.ulc.& eros.in pts.on NSAID   & 40 mg respectiv.  Gastric/duod.ulc.prevent with NSAID ther: 20-40 mg once dly.
       ther. Childr&gt;20 kg: Short term treatm.(up to 3 mnths) of sev. ulcerat.  NSAID assoc.gastroduod.les: 20 mg once dly. with heal.gen.with-  H.Pylori assoc.ulc.& relapse prevent.of such ulc: 20 mg in com-
       reflux oesophagit.resist.to prev. med. treatm.  in 4 wks. If full heal.not achiev. aft.init.course contin.for furth.4 wks.  binat.with amoxicillin 1 g and clarithromycin 500 mg 2xdly x7 days.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page211.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page207.html">207</a>&nbsp;&nbsp;&nbsp;<a href="page208.html">208</a>&nbsp;&nbsp;&nbsp;<a href="page209.html">209</a>&nbsp;&nbsp;&nbsp;<a href="page210.html">210</a>&nbsp;&nbsp;&nbsp;<a href="page211.html">211</a>&nbsp;&nbsp;&nbsp;<a href="page212.html">212</a>&nbsp;&nbsp;&nbsp;<a href="page213.html">213</a>&nbsp;&nbsp;&nbsp;<a href="page214.html">214</a>&nbsp;&nbsp;&nbsp;<a href="page215.html">215</a>&nbsp;&nbsp;&nbsp;<a href="page216.html">216</a>&nbsp;&nbsp;&nbsp;<a href="page217.html">217</a>
             </td>
             <td width="35%"><a href="page213.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page213.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
